These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35752935)

  • 1. Advanced strategies in glycosylation prediction and control during biopharmaceutical development: Avenues toward industry 4.0.
    Puranik A; Saldanha M; Chirmule N; Dandekar P; Jain R
    Biotechnol Prog; 2022 Sep; 38(5):e3283. PubMed ID: 35752935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the potential of machine learning for more efficient development and production of biopharmaceuticals.
    Puranik A; Dandekar P; Jain R
    Biotechnol Prog; 2022 Nov; 38(6):e3291. PubMed ID: 35918873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in Biologic Therapeutic N-Glycan Preparation Techniques and Analytical Methods for Facilitating Biomanufacturing Automation.
    Tiwold EK; Gyorgypal A; Chundawat SPS
    J Pharm Sci; 2023 Jun; 112(6):1485-1491. PubMed ID: 36682489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automation of Immunoglobulin Glycosylation Analysis.
    Hendel JL; Gardner RA; Spencer DIR
    Exp Suppl; 2021; 112():173-204. PubMed ID: 34687010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated High-Throughput Permethylation for Glycosylation Analysis of Biologics Using MALDI-TOF-MS.
    Shubhakar A; Kozak RP; Reiding KR; Royle L; Spencer DI; Fernandes DL; Wuhrer M
    Anal Chem; 2016 Sep; 88(17):8562-9. PubMed ID: 27479043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technology outlook for real-time quality attribute and process parameter monitoring in biopharmaceutical development-A review.
    Wasalathanthri DP; Rehmann MS; Song Y; Gu Y; Mi L; Shao C; Chemmalil L; Lee J; Ghose S; Borys MC; Ding J; Li ZJ
    Biotechnol Bioeng; 2020 Oct; 117(10):3182-3198. PubMed ID: 32946122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal Cell Expression Systems.
    Butler M; Reichl U
    Adv Biochem Eng Biotechnol; 2021; 175():1-36. PubMed ID: 29134458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Data integrity within the biopharmaceutical sector in the era of Industry 4.0.
    Alosert H; Savery J; Rheaume J; Cheeks M; Turner R; Spencer C; S Farid S; Goldrick S
    Biotechnol J; 2022 Jun; 17(6):e2100609. PubMed ID: 35318814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for Automated Enzymatic Glycan Synthesis (AEGS).
    Hussnaetter KP; Palm P; Pich A; Franzreb M; Rapp E; Elling L
    Biotechnol Adv; 2023 Oct; 67():108208. PubMed ID: 37437855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State-of-the-Art Glycomics Technologies in Glycobiotechnology.
    Pralow A; Cajic S; Alagesan K; Kolarich D; Rapp E
    Adv Biochem Eng Biotechnol; 2021; 175():379-411. PubMed ID: 33112988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-line product quality monitoring during biopharmaceutical manufacturing using computational Raman spectroscopy.
    Wang J; Chen J; Studts J; Wang G
    MAbs; 2023; 15(1):2220149. PubMed ID: 37288839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosylation Analysis of Therapeutic Glycoproteins Produced in CHO Cells.
    Carillo S; Mittermayr S; Farrell A; Albrecht S; Bones J
    Methods Mol Biol; 2017; 1603():227-241. PubMed ID: 28493134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Customized protein glycosylation to improve biopharmaceutical function and targeting.
    Van Landuyt L; Lonigro C; Meuris L; Callewaert N
    Curr Opin Biotechnol; 2019 Dec; 60():17-28. PubMed ID: 30554064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbial technologies for biotherapeutics production: Key tools for advanced biopharmaceutical process development and control.
    Zalai D; Kopp J; Kozma B; Küchler M; Herwig C; Kager J
    Drug Discov Today Technol; 2020 Dec; 38():9-24. PubMed ID: 34895644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-glycans of complex glycosylated biopharmaceuticals and their impact on protein clearance.
    Higel F; Sandl T; Kao CY; Pechinger N; Sörgel F; Friess W; Wolschin F; Seidl A
    Eur J Pharm Biopharm; 2019 Jun; 139():123-131. PubMed ID: 30905778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying a robust design space for glycosylation during monoclonal antibody production.
    St Amand MM; Hayes J; Radhakrishnan D; Fernandez J; Meyer B; Robinson AS; Ogunnaike BA
    Biotechnol Prog; 2016 Sep; 32(5):1149-1162. PubMed ID: 27273898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of manipulated variables for a glycosylation control strategy.
    St Amand MM; Radhakrishnan D; Robinson AS; Ogunnaike BA
    Biotechnol Bioeng; 2014 Oct; 111(10):1957-70. PubMed ID: 24728980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosylation of monoclonal antibody products: Current status and future prospects.
    Batra J; Rathore AS
    Biotechnol Prog; 2016 Sep; 32(5):1091-1102. PubMed ID: 27677099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive manipulation of glycosylation profiles across development scales.
    Loebrich S; Clark E; Ladd K; Takahashi S; Brousseau A; Kitchener S; Herbst R; Ryll T
    MAbs; 2019; 11(2):335-349. PubMed ID: 30252592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein N-glycosylation in eukaryotic microalgae and its impact on the production of nuclear expressed biopharmaceuticals.
    Mathieu-Rivet E; Kiefer-Meyer MC; Vanier G; Ovide C; Burel C; Lerouge P; Bardor M
    Front Plant Sci; 2014; 5():359. PubMed ID: 25183966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.